Loading…
Vitamin D supplementation of 4000 IU daily and cardiac function in patients with advanced heart failure: The EVITA trial
Data regarding the effects of vitamin D on cardiac function are inconclusive. In a post-hoc analysis of the EVITA (Effect of vitamin D on mortality in heart failure) trial, we investigated whether a daily vitamin D3 supplement of 4000 IU for three years affects echocardiography parameters like left...
Saved in:
Published in: | International journal of cardiology 2019-04, Vol.280, p.117-123 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Data regarding the effects of vitamin D on cardiac function are inconclusive.
In a post-hoc analysis of the EVITA (Effect of vitamin D on mortality in heart failure) trial, we investigated whether a daily vitamin D3 supplement of 4000 IU for three years affects echocardiography parameters like left ventricular end-diastolic diameter (LVEDD), LV end-systolic diameter (LVESD), and LV ejection fraction (LVEF) in patients with advanced heart failure (HF) and 25‑hydroxyvitamin D levels 0.05). However, in the subgroup of patients aged ≥50 years, vitamin D treatment was associated with an increase in LVEF of 2.73% (95%CI: 0.14 to 5.31%) at 12 months post-randomization (n = 311). The increase was slightly attenuated to 2.60% (95%CI: −2.47 to 7.67%) at 36 months post-randomization (n = 242).
Our data indicate that vitamin D supplementation does not significantly improve cardiac function in all patients with advanced HF. However, vitamin D probably improves LV function in HF patients aged ≥50 years.
•The effect of vitamin D on cardiac function is hotly debated but available data are inconclusive.•We investigated the effect of a daily vitamin D3 supplement of 4,000 IU for three years on cardiac function.•Vitamin D supplementation may not improve cardiac function in all patients with heart failure, but probably in patients aged ≥ 50 years. |
---|---|
ISSN: | 0167-5273 1874-1754 |
DOI: | 10.1016/j.ijcard.2019.01.027 |